MAPT and early-onset autosomal dominant Alzheimer disease: TTBK1 and TTBK2 were originally purified on the basis of their kinase activity on the microtubule binding protein tau at several pathological phospho-tau epitopes known to accumulate in Alzheimer's disease [31], [38], [39], [46].